ctrl K

Price Alert

Mural Oncology (MURA)

NASDAQ: MURA · Real-Time Price · USD

1.77

0.00 (0.00%)

At close: Aug 15, 2025, 3:59 PM

1.79

1.13%

After-hours: Aug 15, 2025, 05:02 PM EDT

Mural Oncology Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	115.46M	270.85M	-19.39M	-25.31M
Short-Term Investments	28.92M	n/a	n/a	n/a
Long-Term Investments	n/a	258K	n/a	n/a
Other Long-Term Assets	1.98M	n/a	n/a	n/a
Receivables	51K	5.55M	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	805K	787K	1.83M	2.04M
Total Current Assets	152.92M	277.34M	4.82M	4.24M
Property-Plant & Equipment	14.5M	24.15M	28.93M	30.87M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	16.48M	24.41M	28.93M	30.87M
Total Assets	169.39M	301.75M	33.75M	35.11M
Account Payables	2.06M	5.97M	2.97M	10.59M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	5.56M	6.1M	5.84M	5.92M
Other Current Liabilities	18.58M	4.99M	19.8M	4.52M
Total Current Liabilities	26.2M	29.02M	41.56M	33.25M
Long-Term Debt	n/a	n/a	13.54M	19.39M
Other Long-Term Liabilities	235K	n/a	-13.24M	-19.03M
Total Long-Term Liabilities	2.7M	8.91M	13.85M	19.74M
Total Liabilities	28.89M	37.93M	55.41M	52.99M
Total Debt	8.02M	15.01M	19.39M	25.31M
Common Stock	171K	167K	n/a	n/a
Retained Earnings	-159.37M	-30.86M	n/a	n/a
Comprehensive Income	n/a	n/a	-21.66M	-17.88M
Shareholders Equity	140.5M	263.82M	-21.66M	-17.88M
Total Investments	28.92M	258K	n/a	n/a